Empresa Gentian Diagnostics AS Oslo Bors
Acciones
NO0010748866
Equipo médico, suministros y distribución
Resumen de negocios
Ventas por actividad
NOK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Renal Diagnostic
41,7
%
| 40 | 39,3 % | 56 | 41,7 % | +40,92 % |
Inflammation Diagnostic
38,3
%
| 43 | 42,2 % | 52 | 38,3 % | +20,72 % |
Other Diagnostic
20,0
%
| 19 | 18,5 % | 27 | 20,0 % | +44,07 % |
Ventas por región
NOK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe
68,6
%
| 72 | 70,4 % | 93 | 68,6 % | +29,60 % |
Asia
24,9
%
| 24 | 23,2 % | 34 | 24,9 % | +42,63 % |
United States
6,5
%
| 6 | 6,4 % | 9 | 6,5 % | +35,10 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Njaal Kind
CEO | Chief Executive Officer | 52 | 02/01/18 |
Hilja Ibert
CHM | Chairman | - | 16/07/18 |
Chief Tech/Sci/R&D Officer | - | - | |
Torsten Knüttel
CTO | Chief Tech/Sci/R&D Officer | - | 05/08/19 |
General Counsel | - | - | |
Markus Jaquemar
PRN | Corporate Officer/Principal | - | - |
Jack Andreassen
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - | |
Kjersti Grimsrud
BRD | Director/Board Member | 63 | - |
Director/Board Member | 49 | 01/09/13 | |
Hilja Ibert
CHM | Chairman | - | 16/07/18 |
Monika Neuman
BRD | Director/Board Member | 59 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 15 422 350 | 8 458 743 ( 54,85 %) | 0 | 54,85 % |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,67 % | 12,32 mil M | |
-5,19 % | 8066,19 M | |
+28,50 % | 5522,13 M | |
-8,09 % | 4212,04 M | |
-55,31 % | 2993,91 M | |
+13,49 % | 2732,77 M | |
-1,34 % | 2429,06 M | |
+32,24 % | 2288,95 M | |
-3,55 % | 1887,43 M |